Cargando…

Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay

A monoclonal antibody (mAb) against zearalenone (ZEN) was produced using ZEN-carboxymethoxylamine and -BSA conjugates. Antibody produced by one clone showing a very high binding ability was selected and found to have a higher affinity for ZEN compared to a commerciall ZEN antibody. We developed two...

Descripción completa

Detalles Bibliográficos
Autores principales: Cha, Sang-Ho, Kim, Sung-Hee, Bischoff, Karyn, Kim, Hyun-Jeong, Son, Seong-Wan, Kang, Hwan-Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Veterinary Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386336/
https://www.ncbi.nlm.nih.gov/pubmed/22705733
http://dx.doi.org/10.4142/jvs.2012.13.2.119
_version_ 1782236968411725824
author Cha, Sang-Ho
Kim, Sung-Hee
Bischoff, Karyn
Kim, Hyun-Jeong
Son, Seong-Wan
Kang, Hwan-Goo
author_facet Cha, Sang-Ho
Kim, Sung-Hee
Bischoff, Karyn
Kim, Hyun-Jeong
Son, Seong-Wan
Kang, Hwan-Goo
author_sort Cha, Sang-Ho
collection PubMed
description A monoclonal antibody (mAb) against zearalenone (ZEN) was produced using ZEN-carboxymethoxylamine and -BSA conjugates. Antibody produced by one clone showing a very high binding ability was selected and found to have a higher affinity for ZEN compared to a commerciall ZEN antibody. We developed two direct competitive ELISA systems using the selected antibody (ZEN-coated and anti-ZEN antibody-coated ELISA). Quantitative ranges for the anti-ZEN antibody-coated ELISA and ZEN-coated ELISA were from 25 to 750 ppb and from 12.5 to 100 ppb, respectively. The detection limit of both methods as measured with standard solutions was 10 ppb. The intra-plate and inter-well variation of both ELISAs were less than 10%. The IC(50) values for α-zearalenol, β-zearalenol, α-zearalanol, and β-zearalanol compared to ZEN were 108.1, 119.3, 114.1, and 130.3% for the ZEN-coated ELISA. These values were 100.7, 120.7, 121.6, and 151.6% for the anti-ZEN antibody-coated ELISA. According to the anti-ZEN antibody-coated ELISA, the average recovery rates of ZEN from spiked animal feed containing 150 to 600 ng/mL of ZEN ranged from 106.07 to 123.00% with 0.93 to 2.28% coefficients of variation. Our results demonstrate that the mAb developed in this study could be used to simultaneously screen for ZEN and its metabolites in feed.
format Online
Article
Text
id pubmed-3386336
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Korean Society of Veterinary Science
record_format MEDLINE/PubMed
spelling pubmed-33863362012-07-09 Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay Cha, Sang-Ho Kim, Sung-Hee Bischoff, Karyn Kim, Hyun-Jeong Son, Seong-Wan Kang, Hwan-Goo J Vet Sci Original Article A monoclonal antibody (mAb) against zearalenone (ZEN) was produced using ZEN-carboxymethoxylamine and -BSA conjugates. Antibody produced by one clone showing a very high binding ability was selected and found to have a higher affinity for ZEN compared to a commerciall ZEN antibody. We developed two direct competitive ELISA systems using the selected antibody (ZEN-coated and anti-ZEN antibody-coated ELISA). Quantitative ranges for the anti-ZEN antibody-coated ELISA and ZEN-coated ELISA were from 25 to 750 ppb and from 12.5 to 100 ppb, respectively. The detection limit of both methods as measured with standard solutions was 10 ppb. The intra-plate and inter-well variation of both ELISAs were less than 10%. The IC(50) values for α-zearalenol, β-zearalenol, α-zearalanol, and β-zearalanol compared to ZEN were 108.1, 119.3, 114.1, and 130.3% for the ZEN-coated ELISA. These values were 100.7, 120.7, 121.6, and 151.6% for the anti-ZEN antibody-coated ELISA. According to the anti-ZEN antibody-coated ELISA, the average recovery rates of ZEN from spiked animal feed containing 150 to 600 ng/mL of ZEN ranged from 106.07 to 123.00% with 0.93 to 2.28% coefficients of variation. Our results demonstrate that the mAb developed in this study could be used to simultaneously screen for ZEN and its metabolites in feed. The Korean Society of Veterinary Science 2012-06 2012-06-15 /pmc/articles/PMC3386336/ /pubmed/22705733 http://dx.doi.org/10.4142/jvs.2012.13.2.119 Text en © 2012 The Korean Society of Veterinary Science. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Cha, Sang-Ho
Kim, Sung-Hee
Bischoff, Karyn
Kim, Hyun-Jeong
Son, Seong-Wan
Kang, Hwan-Goo
Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay
title Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay
title_full Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay
title_fullStr Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay
title_full_unstemmed Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay
title_short Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay
title_sort production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386336/
https://www.ncbi.nlm.nih.gov/pubmed/22705733
http://dx.doi.org/10.4142/jvs.2012.13.2.119
work_keys_str_mv AT chasangho productionofahighlygroupspecificmonoclonalantibodyagainstzearalenoneanditsapplicationinanenzymelinkedimmunosorbentassay
AT kimsunghee productionofahighlygroupspecificmonoclonalantibodyagainstzearalenoneanditsapplicationinanenzymelinkedimmunosorbentassay
AT bischoffkaryn productionofahighlygroupspecificmonoclonalantibodyagainstzearalenoneanditsapplicationinanenzymelinkedimmunosorbentassay
AT kimhyunjeong productionofahighlygroupspecificmonoclonalantibodyagainstzearalenoneanditsapplicationinanenzymelinkedimmunosorbentassay
AT sonseongwan productionofahighlygroupspecificmonoclonalantibodyagainstzearalenoneanditsapplicationinanenzymelinkedimmunosorbentassay
AT kanghwangoo productionofahighlygroupspecificmonoclonalantibodyagainstzearalenoneanditsapplicationinanenzymelinkedimmunosorbentassay